MarketResearchReports.Biz

Biopsy Devices Market Forecast by Products (Needles, Guidance Systems, Guns Reagents), Regions, Application, Companies

Biopsy Devices Market Globally is projected to reach USD 3 Billion, experiencing a significant growth from 2018 to 2024.

 

Albany, NY -- (SBWIRE) -- 02/23/2018 -- Biopsy Devices consist of tools or systems which are used for the diagnosis and treatment of cancer prevalence and increasing demand for minimally invasive procedures.

The cases of increasing cancer prevalence, such as breast, prostate, & lung, with the shift towards minimally invasive surgeries and increasing geriatric population, are driving the growth of this market. The rapid technological advancements and raising public awareness are also the driving factors for the Biopsy Devices market.

Renub Research report titled "Biopsy Devices Market, Global Forecast, by Products (Biopsy Needles, Guidance Systems, Biopsy Guns Reagents and kits and others), Regions (North America, Europe, Asia-Pacific & Rest of the World), Application (Breast Biopsy, Lung Biopsy, Prostate Biopsy and Others) Companies (C. R. Bard, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, Cardinal Health, Inc., Olympus Corporation, Boston Scientific Corporation, Medtronic plc, Hologic, Inc.)" provides a complete analysis of Global Biopsy Devices Market.

Get the sample copy of report : https://www.marketresearchreports.biz/sample/sample/1572620

By Segment – Biopsy Devices Market Analysis

Biopsy Needles is an attractive market in global Biopsy Devices market. While with the rising implementation of Biopsy Guns in surgery, this segment is expected to grow at a significant rate during the forecast period. Further, the report also covers the market of Guidance system (Ultrasound-guided, Stereotactic-guided, Clinically-guided and Reagents & kits system. The market for above mentioned equipments are positively influenced by factors like increasing cancer prevalence, such as breast, prostate, & lung, with the shift towards minimally invasive surgeries.

By Application

Breast Biopsy and Lung Biopsy market share holds significant percentage of Biopsy Devices Market. Prostate Biopsy market share is growing year on year.

By Region

Geographically, North America and Europe holds the considerable market share of the Biopsy Devices Market. Asia-Pacific Biopsy Devices Market is expected to grow at the faster rate over the forecasting period.

Companies Analysis

The key players in this industry include C. R. Bard, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, Cardinal Health, Inc., Olympus Corporation, Boston Scientific Corporation, Medtronic plc, and Hologic, Inc. The company focuses on the development of new products, partnerships and acquisitions to maintain their positions in the market.

All the 8 companies studied in the report have been studied from 4 points

Overview

Business Strategy – This section provides company marketing strategy
Merger & Acquisition – This section captures 5 years M&A data
Financial Insight – This section provides sales of (2010 to 2017) & forecast (2018 to 2024)
This 154 page report with 59 Figures and 2 Tables provides a complete analysis of the Global Biopsy Devices Market, Forecast key Growth Drivers and Challenges.

Get more information of this market @ https://www.marketresearchreports.biz/reports/1572620/biopsy-devices-global-forecast-by-market-research-reports

Biopsy Segments Covered in the Report:

Biopsy Needles
Guidance Systems
Biopsy Guns
Reagents and kits
Others

Regional Market Covered in the Report:

North America
Europe
Asia-Pacific
Rest of the World

Key Companies Covered in the Report:

C. R. Bard, Inc.
Becton, Dickinson and Company
B. Braun Melsungen AG
Cardinal Health, Inc.
Olympus Corporation
Boston Scientific Corporation
Medtronic plc
Hologic, Inc.